So why is the maker of blockbuster diabetes and weight loss drugs that defined a new market now stuck chasing Eli Lilly
Eventually, they will see a gastroenterologist who diagnoses them with irritable bowel syndrome
Competing interests DB received presentation fees (TEVA, Novartis and Pfizer), travel fees (Allergan, TEVA, Pfizer, Abbvie and Lundbeck), advisory board fees (Novartis, Lilly, Teva, Lundbeck, Pfizer and Abbvie) and participated in clinical trials (TEVA, Lundbeck, Novartis, Lilly and Novo Nordisk Foundation) outside of the submitted work
Beverage giants had already been innovating with smaller soda formats to reduce calories (see for example 7.5oz mini cans from Coca-Cola, Sprite and Fanta): expect to see more miniature formats on shelves.